Nearly 80% of well-differentiated in situ duct carcinomas (g1 DCIS) have been shown to be multicentric (multilobar) lesions, while most in situ poorly differentiated duct carcinomas (g3 DCIS) were unifocal (unilobar) lesions. Here we present a clonality study of 15 cases of DCIS, all showing multiple foci. Twelve of these cases were associated with an invasive duct carcinoma. Fifteen cases of female breast cancer patients all showing multiple DCIS foci (5 g1 DCIS, 5 g2 DCIS, 5 g3 DCIS) were randomly selected and histologically studied using large histological sections. Care was taken to laser-microdissect DCIS foci that were most distantly located from one another in the same large section, and pertinent cells were genetically studied. Inva...
Microenvironmental and molecular factors mediating the progression of Breast Ductal Carcinoma In Sit...
Comparative genomic hybridization (CGH) has been the technique of choice over the last 10 years for ...
INTRODUCTION: Lobular carcinoma in situ (LCIS) has been accepted as a marker of risk for the develop...
SummaryNearly 80% of well-differentiated in situ duct carcinomas (g1 DCIS) have been shown to be mul...
Nearly 80% of well-differentiated in situ duct carcinomas (g1 DCIS) have been shown to be multicentr...
Although ductal carcinoma in situ (DCIS) of the breast is accepted as a potential precursor lesion f...
Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and, despite tr...
Aim Aim of the present study is to evaluate the risk of residual neoplastic foci, in patients treate...
<p>Ductal carcinoma in situ (DCIS) is a precursor lesion of invasive ductal carcinoma (IDC) of the b...
Ductal carcinoma in situ (DCIS) is a precursor lesion of invasive ductal carcinoma (IDC) of the brea...
Abstract Background Ductal carcinoma in situ (DCIS) i...
Ductal carcinoma in situ (DCIS) is a non‐invasive form of breast cancer where cells restricted to th...
Background: Simultaneous ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) is very co...
Abstract Ductal carcinoma in situ (DCIS) is an intraductal neoplastic proliferation of epithelial ce...
Background: Ductal carcinoma in situ (DCIS) is considered to be a precursor of invasive breast cance...
Microenvironmental and molecular factors mediating the progression of Breast Ductal Carcinoma In Sit...
Comparative genomic hybridization (CGH) has been the technique of choice over the last 10 years for ...
INTRODUCTION: Lobular carcinoma in situ (LCIS) has been accepted as a marker of risk for the develop...
SummaryNearly 80% of well-differentiated in situ duct carcinomas (g1 DCIS) have been shown to be mul...
Nearly 80% of well-differentiated in situ duct carcinomas (g1 DCIS) have been shown to be multicentr...
Although ductal carcinoma in situ (DCIS) of the breast is accepted as a potential precursor lesion f...
Ductal carcinoma in situ (DCIS) is the most common form of preinvasive breast cancer and, despite tr...
Aim Aim of the present study is to evaluate the risk of residual neoplastic foci, in patients treate...
<p>Ductal carcinoma in situ (DCIS) is a precursor lesion of invasive ductal carcinoma (IDC) of the b...
Ductal carcinoma in situ (DCIS) is a precursor lesion of invasive ductal carcinoma (IDC) of the brea...
Abstract Background Ductal carcinoma in situ (DCIS) i...
Ductal carcinoma in situ (DCIS) is a non‐invasive form of breast cancer where cells restricted to th...
Background: Simultaneous ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) is very co...
Abstract Ductal carcinoma in situ (DCIS) is an intraductal neoplastic proliferation of epithelial ce...
Background: Ductal carcinoma in situ (DCIS) is considered to be a precursor of invasive breast cance...
Microenvironmental and molecular factors mediating the progression of Breast Ductal Carcinoma In Sit...
Comparative genomic hybridization (CGH) has been the technique of choice over the last 10 years for ...
INTRODUCTION: Lobular carcinoma in situ (LCIS) has been accepted as a marker of risk for the develop...